|
|
|
WHO Collaborating Centres
in India
|
|
Communicable Diseases & Disease Surveillance
|
|
|
|
Centre Description
|
CC No
|
IND-057-[SE]
|
|
Title
|
Tuberculosis
Research and Training
|
|
Head of Institution
|
Dr
P.R. Narayanan
|
|
PI Name
|
Dr
P.R. Narayanan
|
PI Designation
|
Director
|
|
Institute Name
|
Tuberculosis
Research Centre, Chennai
|
|
Address
|
Indian
Council of Medical Research
|
Phone
|
(044)
28369500/28369600
|
|
|
Mayor V.R. Ramanathan Road, Old Spur Tank Road, Chetput
|
Fax
|
91-044-28362528/28362525
|
|
|
Chennai.600031
|
E-Mail
|
nrparanj@md2.vsnl.net.in
|
|
|
India
|
|
HQ Unit
|
STB
|
SEARO File
|
T9/72/1
|
|
SEARO Department
|
CDS
|
Technical Unit
|
STB
|
|
Area Code
|
TB
|
|
Area
|
Tuberculosis
|
|
Functions of the Centre
|
|
|
|
|
Status Details
|
|
Initial Designation Date
|
16-Sep-1985
|
Redesignation due on
|
13-Jun-2009
|
|
Last Designation Date
|
14-Jun-2005
|
|
Current Status
|
Redesignated
|
|
Status Comments
|
The insititute has been redesignated
vide RD's letter no. T9/72/1 dated 14 June 2005
|
|
|
|
Introduction
|
|
|
|
Origin of the proposal,
technical programme which is sponsoring, reasons
for proposed designation
|
Redesignation upon successful previous tenure.
|
|
Steps that have led to this
proposal, eg site-visits by WHO staff, previous
participation of the institution, joint development of a workplan, etc.
|
Visit
by Dr Tom Frieden and other research work carried
out by WHO through the institution.
|
|
Comments & Composition of
the Institute
|
The
Tuberculosis Research Centre (TRC), formerly known as Tuberculosis
Chemotherapy Centre is a permanent research institute of the Indian Council
of Medical Research (ICMR), an autonomous organization under the Ministry
of Health and Family Welfare, Government of India. It was established in
1955, jointly by the ICMR, World Health Organization, Government of Tamil Nadu, and USPHS to determine the feasibility, efficacy
and safety of domiciliary chemotherapy for sputum positive pulmonary
tuberculosis patients.
|
|
Statutory functions of the
institution ; formal links with other institutions
|
See
the attached institutional profile.
|
|
|
|
|
|
Administrative Structure
|
|
|
|
Administrative and Scientific
Responsibility
|
Dr
P.R. Narayanan
|
|
National and International
Advisory Boards ; Composition & Terms of Reference
|
See
attached institutional profile.
|
|
List of Senior Staff
|
See
attached institutional profile.
|
|
Facilities Available (labs,
training facilities, documentation centre, etc.)
|
See
attached institutional profile.
|
|
|
|
Workplan
|
|
|
|
Terms of Reference
|
1. To conduct studies on the efficacy and
feasibility of TB case management including for MDR-TB and HIV related TB
in order to determine the effectiveness of current recommendations for
diagnostic and treatment policies of national TB control programmes; and to determine the efficacy of treatment
of latent TB infection in HIV-TB;
2. to conduct operational and basic research, aimed at providing the
evidence base for best practices, measuring the epidemiological impact of
the control strategies and developing new diagnostic tools; the research
agenda should be determined by the needs for improving the TB programme, as part of overarching health systems
development;
3. to develop and test training materials/modules
addressing training needs for national TB programmes,
including TB-HIV and laboratory.
4. to avail the most appropriate laboratory services, as part of the
Institute's role as a national and supranational mycobacteriology
reference laboratory, to support building laboratory capacity in Member
countries, including monitoring of drug resistance, undertaking
identification tests for classifying mycobacteria,
and providing technical support to Member countries, when requested.
|
|
|
|
|
List Of Activities
|
|
|
|
Activity ID
|
Activity Title
|
Year1
|
Year2
|
Year3
|
Year4
|
|
1
|
To conduct studies
on HIV-related tuberculosis in order to determine the effectiveness of
current recommendations for diagnostic and treatment policies.
|
Yes
|
Yes
|
Yes
|
Yes
|
|
10
|
To carry out
monitoring of drug-resistance in tuberculosis patients in India and
other countries in the South-East Asia Region;
|
Yes
|
Yes
|
Yes
|
Yes
|
|
11
|
To undertake
identification tests for classification and typing of mycobacteria;
|
Yes
|
Yes
|
Yes
|
Yes
|
|
12
|
To carry out
research on standardization and simplification of laboratory procedures for
diagnosis of tuberculosis, including the development of immunodiagnostic
tests;
|
Yes
|
Yes
|
Yes
|
Yes
|
|
13
|
To provide
supervision of the work of bacteriology laboratories undertaking
tuberculosis bacteriology; and
|
Yes
|
Yes
|
Yes
|
Yes
|
|
14
|
To provide training
to laboratory personnel for undertaking standardized laboratory procedures
for bacteriological and immunodiagnostic tests for tuberculosis.
|
Yes
|
Yes
|
Yes
|
Yes
|
|
2
|
To conduct clinical
trials and feasibility studies on preventive treatment of latent
tuberculosis infection in HIV-infected persons.
|
Yes
|
Yes
|
Yes
|
Yes
|
|
3
|
To conduct training
of trainers and develop training materials to improve management of HIV
related tuberculosis
|
No
|
Yes
|
Yes
|
Yes
|
|
4
|
To carry out
operational research to strengthen and integrate HIV and TB control programmes.
|
No
|
Yes
|
Yes
|
Yes
|
|
5
|
To develop and test
management strategies for patients with MDRTB
|
No
|
Yes
|
Yes
|
Yes
|
|
6
|
To carry out
controlled clinical trials for the treatment of pulmonary and
extra-pulmonary tuberculosis.
|
Yes
|
Yes
|
Yes
|
Yes
|
|
7
|
To carry out
epidemiological studies in the field of tuberculosis in general and
evaluate the epidemiological impact of DOTS in particular.
|
Yes
|
Yes
|
Yes
|
Yes
|
|
8
|
To carry out
operational and basic research for better control of tuberculosis
|
Yes
|
Yes
|
Yes
|
Yes
|
|
9
|
To conduct training
of trainers and develop training materials to improve DOTS implementation
|
Yes
|
Yes
|
Yes
|
Yes
|
|
|
|

|
|
|
|
|